« Return to News | Drug Sponsors

Amgen to buy Pfizer plant, saving 280 jobs

Friday, March 11, 2011 01:53 PM

Amgen has agreed to buy a Pfizer manufacturing plant at Dun Laoghaire, County Dublin, securing 280 jobs in the process. The transaction is expected to close in the second quarter of the year, according to Fierce Pharma.

Under the agreement, 240 employees will transfer to Amgen; the other 40 will remain employed by Pfizer. Amgen will manufacture Pfizer's products at the facility for an interim period, and Pfizer will lease a portion of the facility from Amgen.

Amgen intends to develop the capability to formulate and fill its biological products at the site and expand manufacturing capabilities. The aseptic operations facility has freeze dry product and liquid vial filling operations.

"As we expand internationally, the Dublin site will help us deliver a growing supply of Amgen medicines for patients worldwide," Madhu Balachandran, senior vice president of Amgen Manufacturing, said in a statement issued by Ireland's Industrial Development Agency (IDA). "We are impressed with the technical expertise and commitment to excellence demonstrated by the employees who work at the Dun Laoghaire site and look forward to welcoming them to Amgen's global manufacturing team."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.